搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Rhodopseudomonas palustris Ketol-acid reductoisomerase (ilvC) CSB-YP632406RAAK
CSB-EP632406RAAK
CSB-BP632406RAAK
CSB-MP632406RAAK
CSB-EP632406RAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Zinc metalloproteinase nas-3 (nas-3) CSB-YP632407CXY
CSB-EP632407CXY
CSB-BP632407CXY
CSB-MP632407CXY
CSB-EP632407CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Probable cation-transporting ATPase K07E3.7 (K07E3.7/K07E3.6), partial CSB-YP632408CXY
CSB-EP632408CXY
CSB-BP632408CXY
CSB-MP632408CXY
CSB-EP632408CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Protein let-99 (let-99), partial CSB-YP632409CXY
CSB-EP632409CXY
CSB-BP632409CXY
CSB-MP632409CXY
CSB-EP632409CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris Fructose-1,6-bisphosphatase class 1 (fbp) CSB-YP632410RAAK
CSB-EP632410RAAK
CSB-BP632410RAAK
CSB-MP632410RAAK
CSB-EP632410RAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris 7-cyano-7-deazaguanine synthase (queC) CSB-YP632411RAAK
CSB-EP632411RAAK
CSB-BP632411RAAK
CSB-MP632411RAAK
CSB-EP632411RAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Protein lin-14 (lin-14), partial CSB-YP632412CXY
CSB-EP632412CXY
CSB-BP632412CXY
CSB-MP632412CXY
CSB-EP632412CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris Integration host factor subunit alpha (ihfA) CSB-YP632413RAAK
CSB-EP632413RAAK
CSB-BP632413RAAK
CSB-MP632413RAAK
CSB-EP632413RAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris Pyridoxine 5'-phosphate synthase (pdxJ) CSB-YP632414RAAK
CSB-EP632414RAAK
CSB-BP632414RAAK
CSB-MP632414RAAK
CSB-EP632414RAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris Protein hfq (hfq) CSB-YP632415RAAK
CSB-EP632415RAAK
CSB-BP632415RAAK
CSB-MP632415RAAK
CSB-EP632415RAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris Serine--tRNA ligase (serS) CSB-YP632416RAAK
CSB-EP632416RAAK
CSB-BP632416RAAK
CSB-MP632416RAAK
CSB-EP632416RAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Uncharacterized NTE family protein M110.7 (M110.7), partial CSB-YP632417CXY
CSB-EP632417CXY
CSB-BP632417CXY
CSB-MP632417CXY
CSB-EP632417CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase (fabZ) CSB-YP632418RAAK
CSB-EP632418RAAK
CSB-BP632418RAAK
CSB-MP632418RAAK
CSB-EP632418RAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris Lipoprotein-releasing system ATP-binding protein LolD 1 (lolD1) CSB-YP632419RAAK
CSB-EP632419RAAK
CSB-BP632419RAAK
CSB-MP632419RAAK
CSB-EP632419RAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris ATP-dependent Clp protease proteolytic subunit (clpP) CSB-YP632420RAAK
CSB-EP632420RAAK
CSB-BP632420RAAK
CSB-MP632420RAAK
CSB-EP632420RAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris Guanylate kinase (gmk) CSB-YP632421RAAK
CSB-EP632421RAAK
CSB-BP632421RAAK
CSB-MP632421RAAK
CSB-EP632421RAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris Glutamyl-tRNA (Gln) amidotransferase subunit A (gatA) CSB-YP632422RAAK
CSB-EP632422RAAK
CSB-BP632422RAAK
CSB-MP632422RAAK
CSB-EP632422RAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Heme transporter hrg-1 (hrg-1), partial CSB-YP632423CXY1
CSB-EP632423CXY1
CSB-BP632423CXY1
CSB-MP632423CXY1
CSB-EP632423CXY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris Thiazole synthase (thiG) CSB-YP632424RAAK
CSB-EP632424RAAK
CSB-BP632424RAAK
CSB-MP632424RAAK
CSB-EP632424RAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Putative UDP-glucuronosyltransferase ugt-47 (ugt-47), partial CSB-YP632425CXY1
CSB-EP632425CXY1
CSB-BP632425CXY1
CSB-MP632425CXY1
CSB-EP632425CXY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>